FDA Clearance Tracker · P830055-S360
ATTUNE Revision Knee System
Last checked: Nov 20, 2026Latest source record: Aug 5, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 5, 2026
Approved
Time to decision
180 days
Received Feb 6, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P830055-S360
- Device name
- ATTUNE Revision Knee System
- Applicant
- Depuy, Inc.
- Applicant location
- Warsaw, IN
- Received
- Feb 6, 2026
- Decided
- Aug 5, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P830055
Device type
- Device type
- Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at DePuy International Ltd., Leeds, LS11 8DT, United Kingdom, as an additional manufacturing site for the ATTUNE Revision Tibial Sleeve products, and a manufacturing site located at Synergy Health Sterilization UK Limited, Reading, Berkshire, RG30 4EA, United Kingdom, as an additional sterilization facility for the ATTUNE Revision Tibial Sleeve products.
Source documents
Other decisions for Depuy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.